Browse Title Index

Issue Title
Vol 21, No 4 (2014) Computerized prescriber order entry in the outpatient oncology setting: from evidence to meaningful use Abstract   PDF   HTML
V. Kukreti, R. Cosby, A. Cheung, S. Lankshear, ST Computerized Prescriber Order Entry Guideline Development Group
Vol 16, No 2 (2009) Concomitant renal cell carcinoma and chronic myelogenous leukemia: use of a targeted approach Details   PDF
Sumanta K Pal, Ravi K Gupta, Gary Dosik, Robert A Figlin
Vol 21, No 3 (2014) Concurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled study Abstract   PDF   HTML
Z. Liang, X. Zhu, L. Li, S. Qu, X. Liang, Z. Liang, F. Su, Y. Li, W. Zhao
Vol 22, No 1 (2015) Concurrent chemoradiotherapy for locally advanced breast cancer—time for a new paradigm? Abstract   PDF   HTML
V. Mandilaras, N. Bouganim, J. Spayne, R. Dent, A. Arnaout, J.F. Boileau, M. Brackstone, S. Meterissian, M. Clemons
Vol 23, No 4 (2016) Concurrent hypopituitarism and leukemic retinopathy in a child with B-precursor acute lymphoblastic leukemia and isolated central nervous system relapse Abstract   PDF   HTML
K.H. Wu, H.P. Wu, H.J. Lin, C.H. Wang, H.Y. Chen, T. Weng, C.T. Peng, Y.H. Chao
Vol 24, No 5 (2017) Conditional survival after a diagnosis of malignant brain tumour in Canada: 2000–2008 Abstract   PDF   HTML
Y. Yuan, J. Ross, Q. Shi, F.G. Davis
Vol 19, No 4 (2012) Conditional survival in Canada: adjusting patient prognosis over time Abstract   PDF   HTML
H. Bryant, G. Lockwood, R. Rahal, L. Ellison
Vol 25, No 2 (2018) Connecting people with cancer to physical activity and exercise programs: a pathway to create accessibility and engagement Abstract   PDF   HTML
D. Santa Mina, C.M. Sabiston, D. Au, A.J. Fong, L.C. Capozzi, D. Langelier, M. Chasen, J. Chiarotto, J.R. Tomasone, J.M. Jones, E. Chang, S.N. Culos-Reed
Vol 20, No 1 (2013) Consensus recommendations for cancer rehabilitation: research and education priorities Abstract   PDF   HTML
S. McEwen, M. Egan, M. Chasen, M. Fitch
Vol 17, No 3 (2010) Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian national expert group Abstract   PDF
W. Kocha, J. Maroun, H. Kennecke, C. Law, P. Metrakos, J. F. Ouellet, R. Reid, C. Roswell, A. Shah, S. Singh, S. Van Uum, R. Wong
Vol 17, No 6 (2010) Consensus recommendations for the use of anti-EGFR therapies in metastatic colorectal cancer Abstract   PDF
C. Cripps, S. Gill, S. Ahmed, B. Colwell, S. Dowden, H. Kennecke, J. Maroun, B. Samson, M. Thirlwell, R. Wong
Vol 22, No 2 (2015) Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5–6, 2014 Abstract   PDF   HTML
S. Ahmed, O. Bathe, S. Berry, D. Buie, J. Davies, C. Doll, S. Dowden, S. Gill, V. Gordon, P. Hebbard, E. Jones, H. Kennecke, S. Koski, M. Krahn, D. Le, H. Lim, C. Lund, Y. Luo, A. Mcffadden, J. Mcghie, K. Mulder, J. Park, F. Rashidi, A. Sami, J. Tan, R. Wong
Vol 18, No 4 (2011) Consensus-based nutritional recommendations for patients with head-and-neck cancer Details   PDF   HTML
E. Isenring
Vol 17, No 6 (2010) Consent to external-beam radiotherapy Abstract   PDF
C. Freeman, H. Lamed, C. Gingras, G. Shenouda
Vol 20, No 1 (2013) Conservative management for an entero-adnexal fistula at initial presentation of advanced ovarian carcinoma Abstract   PDF   HTML
A. Shai, E. Grikshtas, Y. Segev, Moshe Moskovitz, A. Bitterman, M. Steiner, O. Lavie
Vol 16, No 4 (2009) Conservative Treatment of Invasive Bladder Cancer Abstract   PDF
Luis Souhami, Nicholas Rene, Fabio Biagini Cury
Vol 24, No 2 (2017) Consultative workshop proceedings of the Canadian Team to Improve Community-Based Cancer Care Along the Continuum Abstract   PDF   HTML
E. Grunfeld, B. Petrovic, for the CanIMPACT investigators
Vol 15, No 4 (2008) Contemporary Management of Stage I Testicular Seminoma: A Survey of Canadian Abstract   PDF
Rajiv S Samant, Ibraheem Alomary, Paul Genest, Libni Eapen
Vol 24, No 2 (2017) Contextualizing the use of oncologic imaging within treatment phases: imaging trends and modality preferences, 2000–2014 Abstract   PDF   HTML
T.P. Copeland, J.M. Creasman, D.J. Seidenwurm, B.L. Franc
Vol 20, No 3 (2013) Continued success in providing timely palliative radiation therapy at the Rapid Response Radiotherapy Program: a review of 2008–2012 Abstract   PDF   HTML
N. Thavarajah, K. Wong, L. Zhang, G. Bedard, E. Wong, M. Tsao, C. Danjoux, E. Barnes, A. Sahgal, K. Dennis, L. Holden, N. Lauzon, E. Chow
Vol 19, No 5 (2012) Continuity clinics in oncology training programs in Canada Abstract   PDF   HTML
J.M. Croke, M.M. Vickers, C. E, D.Y. Heng, M.N. Reaume, X. Song, J. Meng, T. Asmis, C. Lochrin
Vol 23, No 6 (2016) Controlled settings for lung cancer screening: why do they matter? Considerations for referring clinicians Abstract   PDF   HTML
A. Bharmal, A. Crosskill, S. Lam, H. Bryant
Vol 24, No 5 (2017) Coordination of radiologic and clinical care reduces the wait time to breast cancer diagnosis Abstract   PDF   HTML
E.C. McKevitt, C.K. Dingee, R. Warburton, J.S. Pao, C.J. Brown, C. Wilson, U. Kuusk
Vol 18, No 3 (2011) Cord stem-cell transplantation in Ontario: do we need a public bank? Abstract   PDF   HTML
A. Gassas
Vol 15, No 2 (2008) Coriolus versicolor extracts: clinical relevance in cancer management Abstract   PDF
Maria OP Szeto
Vol 21, No 2 (2014) Corrigendum: A Canadian perspective on the safe administration of bendamustine and the prevention and management of adverse events Abstract   PDF   HTML
J. Koolwine, T. Crosbie, G. Gazzé, R. Turner, J. Wiernikowski, W. Assaily
Vol 20, No 1 (2013) Corrigendum: A first look at participation rates in cervical cancer screening programs in Canada Details   PDF   HTML
Current Oncology
Vol 19, No 3 (2012) Corrigendum: A personalized approach to treatment: use of EGFR tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in Canada Details   PDF   HTML
V. Hirsh, B. Melosky, G. Goss, D. Morris, W. Morzycki
Vol 23, No 5 (2016) Corrigendum: Did the addition of concomitant chemotherapy to radiotherapy improve outcomes in hypopharyngeal cancer? A population-based study Abstract   PDF   HTML
S.F. Hall, R. Griffiths
Vol 23, No 4 (2016) Corrigendum: Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014 Abstract   PDF   HTML
E. Tsvetkova, S. Sud, N. Aucoin, J. Biagi, R. Burkes, B. Samson, S. Brule, C. Cripps, B. Colwell, C. Falkson, M. Dorreen, R. Goel, F. Halwani, C. Marginean, C. Marginean, J. Maroun, N. Michaud, M. Tehfe, M. Thirlwell, M. Vickers, T. Asmis
Vol 18, No 6 (2011) Corrigendum: Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective Abstract   PDF   HTML
A. Oza
Vol 19, No 1 (2012) Corrigendum: Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba Abstract   PDF   HTML
Current Oncology
Vol 20, No 3 (2013) Corrigendum: Ubiquitin pathway and ovarian cancer Abstract   PDF   HTML
Z. Rao, Y. Ding
Vol 24, No 5 (2017) Cost analysis of breast cancer diagnostic assessment programs Abstract   PDF   HTML
G.N. Honein-AbouHaidar, J.S. Hoch, M.J. Dobrow, T. Stuart-McEwan, D.R. McCready, A.R. Gagliardi
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Cost and resource utilization in cervical cancer management: a real-world retrospective cost analysis Abstract   PDF   HTML
I. Cromwell, Z. Ferreira, L. Smith, K. van der Hoek, G. Ogilvie, A. Coldman, S.J. Peacock
Vol 17, No 1 (2010) Cost effectiveness of TAC versus FAC in adjuvant treatment of node-positive breast cancer Abstract   PDF
N. Mittmann, S. Verma, M. Koo, K. Alloul, M. Trudeau
Vol 23, No 3 (2016) Cost impact analysis of Enhanced Recovery After Surgery program implementation in Alberta colon cancer patients Abstract   PDF   HTML
G. Nelson, L.N. Kiyang, A. Chuck, N.X. Thanh, L.M. Gramlich
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Cost implications of unwarranted imaging for distant metastasis in women with early-stage breast cancer in Ontario Abstract   PDF   HTML
K. Thavorn, Z. Wang, D. Fergusson, S. van Katwyk, A. Arnaout, M. Clemons
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Cost trajectories for cancer patients Abstract   PDF   HTML
W.P Wodchis, E. Arthurs, A.I. Khan, S. Gandhi, M. MacKinnon, J. Sussman
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Cost-effectiveness analysis of whole-mount pathology processing for patients with early breast cancer undergoing breast conservation Abstract   PDF   HTML
N.J. Look Hong, G.M. Clarke, M.J. Yaffe, C.M.B. Holloway
Vol 21, No 1 (2014) Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes Abstract   PDF   HTML
A.R. Levy, D. Zou, N. Risebrough, R. Buckstein, T. Kim, N. Brereton
Vol 25, No 1 (2018) Cost-effectiveness of everolimus for the treatment of advanced neuroendocrine tumours of gastrointestinal or lung origin in Canada Abstract   PDF   HTML
A. Chua, A. Perrin, J.F. Ricci, M.P. Neary, M. Thabane
Vol 21, No 4 (2014) Cost-effectiveness of first-line treatments for patients with KRAS wild-type metastatic colorectal cancer Abstract   PDF   HTML
E.M. Ewara, G.S. Zaric, S. Welch, S. Sarma
Vol 21, No 1 (2014) Cost-effectiveness of FOLFIRINOX for first-line treatment of metastatic pancreatic cancer Abstract   PDF   HTML
C.L. Attard, S. Brown, K. Alloul, M.J. Moore
Vol 20, No 5 (2013) Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor–positive metastatic breast cancer in Canada Abstract   PDF   HTML
T.E. Delea, J. Amdahl, A. Chit, M.M. Amonkar
Vol 17, No 1 (2010) Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada Abstract   PDF
C.L. Attard, J.A. Maroun, K. Alloul, D.T. Grima, L.M. Bernard
Vol 23, No 4 (2016) Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada Abstract   PDF   HTML
J. Amdahl, J. Diaz, J. Park, H.R. Nakhaipour, T.E. Delea
Vol 21, No 6 (2014) Cost-effectiveness of pazopanib in advanced soft-tissue sarcoma in Canada Abstract   PDF   HTML
T.E. Delea, J. Amdahl, H.R. Nakhaipour, S.C. Manson, A. Wang, N. Fedor, A. Chit
Vol 23, No 4 (2016) Cost-effectiveness of pazopanib: an example of improved transparency and accessibility of industry-sponsored economic evaluations through publication in peer-reviewed journals Abstract   PDF   HTML
J. Beca, K.K.W. Chan
Vol 20, No 2 (2013) Cost-effectiveness of systemic therapies for metastatic pancreatic cancer Abstract   PDF   HTML
V.C. Tam, Y.J. Ko, N. Mittmann, M.C. Cheung, K. Kumar, S. Hassan, K.K.W. Chan
Vol 19, No 6 (2012) Cost-effectiveness of zoledronic acid compared with clodronate in multiple myeloma Abstract   PDF   HTML
T. E. Delea, K. El Ouagari, J. Rotter, A. Wang, S. Kaura, G.J. Morgan
Vol 23, No 2 (2016) Costs of cervical cancer treatment: population-based estimates from Ontario Abstract   PDF   HTML
C. Pendrith, A. Thind, G.S. Zaric, S. Sarma
Vol 22, No 4 (2015) Cost–utility of adjuvant zoledronic acid in patients with breast cancer and low estrogen levels Abstract   PDF   HTML
N.W.D. Lamond, C. Skedgel, D. Rayson, T. Younis
Vol 19, No 4 (2012) Countercurrents / Is breast cancer staging obsolete? Abstract   PDF   HTML
S. A. Narod
Vol 19, No 3 (2012) Countercurrents / The tip of the iceberg Details   PDF   HTML
S.A. Narod
Vol 20, No 2 (2013) Countercurrents: A new kind of breast cancer gene mutation Details   PDF   HTML
S.A. Narod
Vol 23, No 5 (2016) Countercurrents: Do acronyms belong in the medical literature? Abstract   PDF   HTML
S.A. Narod, H. Ahmed, M.R. Akbari
Vol 20, No 3 (2013) Countercurrents: Salpingectomy to prevent ovarian cancer Abstract   PDF   HTML
S.A. Narod
Vol 22, No 3 (2015) Counterpoint re: “Mammography screening—sticking to the science” Abstract   PDF   HTML
S.A. Narod
Vol 13, No 4 (2006) Cross-Border Referral for Early Breast Cancer: An Analysis of Radiation Fractionation Patterns Abstract   PDF
Ian S Dayes, Timothy J Whelan, Jim A Julian, Michael R Kuettel, Dybesh Regmi, Gordon S Okawara, Malti Patel, Harold I Reiter, Sacha Dubois
Vol 23, No 5 (2016) Cross-comparison of cancer drug approvals at three international regulatory agencies Abstract   PDF   HTML
N. Samuel, S. Verma
Vol 20, No 6 (2013) Cross-disciplinary research in cancer: an opportunity to narrow the knowledge– practice gap Abstract   PDF   HTML
R. Urquhart, E. Grunfeld, L. Jackson, J. Sargeant, G.A. Porter
Vol 22, No 5 (2015) Current definition of locally advanced breast cancer Abstract   PDF   HTML
P.K. Garg, G. Prakash
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Current landscape of immunotherapy for the treatment of metastatic non-small-cell lung cancer Abstract   PDF   HTML
A. Pabani, C.A. Butts
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Current management of castrate-resistant prostate cancer Abstract   PDF
S. J. Hotte, F. Saad
Vol 18, No 5 (2011) Current Oncology receives its first journal impact factor Details   PDF   HTML
Multimed Inc.
Vol 20, No 1 (2013) Current Oncology: it all started 20 years ago ... Details   PDF   HTML
L. Cooper
Vol 24, No 3 (2017) Current practice in total-body irradiation: results of a Canada-wide survey Abstract   PDF   HTML
R.C.N. Studinski, D.J. Fraser, R.S. Samant, M.S. MacPherson
Vol 22, No 4 (2015) Dasatinib for a child with Philadelphia chromosome–positive acute lymphoblastic leukemia and persistently elevated minimal residual disease during imatinib therapy Abstract   PDF   HTML
K.H. Wu, H.P. Wu, T. Weng, C.T. Peng, Y.H Chao
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective Declining conventional cancer treatment and using Complementary and Alternative Medicine: A problem or a challenge? Abstract   PDF
Marja J. Verhoef
Vol 17, No 4 (2010) Dedifferentiated giant cell tumour of bone in the form of low-grade fibroblastic osteogenic sarcoma: case report of a unique presentation with follow-up Abstract   PDF
A. Nahal, A. Ajlan, T. Alcindor, R. Turcotte
Vol 23, No 1 (2016) De-escalation of bone-targeted agents for metastatic prostate cancer Abstract   PDF   HTML
B.Y. Hong, M.F.K. Ibrahim, R. Fernandes, S. Mazzarello, B. Hutton, R. Shorr, M. Clemons
Vol 18, No 3 (2011) Defining the elements for successful implementation of a small-city radiotherapy department Abstract   PDF   HTML
P. Dunscombe, P. S. Craighead
Vol 15, No 4 (2008) Defining the Optimal Treatment Strategy for Localized Prostate Cancer Patients: A Survey of Ongoing Studies at the National Cancer Institute of Canada Clinical Trials Group Abstract   PDF
Wendy R. Parulekar, Michael McKenzie, Kim N Chi, Laurence Klotz, Charles Catton, Michael Brundage, Keyue Ding, Andrea Hiltz, Ralph Meyer, Fred Saad
Vol 16, No 1 (2009) Demographic Profile and Utilization Statistics of a Canadian Inpatient Palliative Care Unit Within a Tertiary Care Setting Abstract   PDF
Julie Napolskikh, Debbie Selby, Margaret Bennett, Edward Chow, Kristin Harris, Emily Sinclair, Jeff Myers
Vol 20, No 5 (2013) Denosumab and giant cell tumour of bone—a review and future management considerations Abstract   PDF   HTML
S.F. Xu, B. Adams, X.C. Yu, M. Xu
Vol 21, No 5 (2014) Design and implementation of a community-based exercise program for breast cancer patients Abstract   PDF   HTML
H.J. Leach, J.M. Danyluk, S.N. Culos-Reed
Vol 15, No 5 (2008) Developing a Methodology for 3-D Correlation of PET-CT Images and Whole-Mount Histopathology in Non-Small Cell Lung Cancer Abstract   PDF
Max Dahele, David Hwang, Chris Peressotti, Laibao Sun, Maggie Kusano, Shaista Okhai, Gail Darling, Martin Yaffe, Curtis Caldwell, Kathy Mah, Jennifer Hornby, Lisa Ehrlich, Simon Raphael, Ming Tsao, Yee C. Ung, A. Behzadi, C. Weigensberg
Vol 24, No 3 (2017) Development and pre-testing of a rehabilitation planning consultation for head-and-neck cancer Abstract   PDF   HTML
S. McEwen, C. Dunphy, J. Norman Rios, A. Davis, J. Jones, A. Lam, I. Poon, R. Martino, J. Ringash
Vol 24, No 5 (2017) Development of an online, patient-centred decision aid for patients with oropharyngeal cancer in the transoral robotic surgery era Abstract   PDF   HTML
J.S. Lam, G.M. Scott, D.A. Palma, K. Fung, A.V. Louie
Vol 16, No 2 (2009) Development of Cell Cycle Inhibitors for Cancer Therapy Details   PDF
Gary K. Schwartz, Mark Dickson
Vol 22, No 4 (2015) Diagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care? Abstract   PDF   HTML
R. VanderMeer, S. Chambers, A. Van Dam, J.C. Cutz, J.R. Goffin, P.M. Ellis
Vol 17, No 2 (2010) Diagnosis and management of hepatocellular carcinoma: results of a consensus meeting of The Ottawa Hospital Cancer Centre Abstract   PDF
T. Asmis, F. Balaa, L. Scully, D. Papadatos, C. Marginean, N. Fasih, T. Shaw-Stiffel, R. Goel
Vol 24, No 3 (2017) Diagnostic value of epidermal growth factor, cancer antigen 125, and cancer antigen 15-3 in bronchoalveolar lavage fluid of lung cancer Abstract   PDF   HTML
S. Sun, Z. Chen, C. Cao, B. Wu, B. Wang, Y. Yu, Z. Chen, Z. Hu, Z. Deng
Vol 21, No 1 (2014) Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer Abstract   PDF   HTML
E. Polat, U. Duman, M. Duman, A.E. Atici, E. Reyhan, T. Dalgic, E.B. Bostanci, S. Yol
Vol 23, No 4 (2016) Did the addition of concomitant chemotherapy to radiotherapy improve outcomes in hypopharyngeal cancer? A population-based study Abstract   PDF   HTML
S.F. Hall, R. Griffiths
Vol 13, No 4 (2006) Diffusion and dissemination of evidence-based dietary srategies for the prevention of cancer Details   PDF
Parminder Raina, Donna Ciliska, Paula Robinson, Tanya Armour, Peter Ellis, Melissa Brouwers, Mary Gauld, Fulvia Baldassarre
Vol 18, No 3 (2011) Digital necrosis induced by erlotinib treatment in metastatic adenocarcinoma of the lung Abstract   PDF   HTML
P. Ballardini, G. Margutti, R. Manfredini
Vol 20, No 6 (2013) Direct cost for initial management of prostate cancer: a systematic review Abstract   PDF   HTML
C. Sanyal, A.G. Aprikian, S. Chevalier, F.L. Cury, A. Dragomir
Vol 19, No 2 (2012) Disappearing breast cancers Details   PDF   HTML
S.A. Narod
Vol 19, No 6 (2012) Disparities in timeliness of care for U.S. Medicare patients diagnosed with cancer Abstract   PDF   HTML
M.T. Halpern, D.J. Holden
Vol 19, No 6 (2012) Disparity in cancer care: a Canadian perspective Abstract   PDF   HTML
S. Ahmed, R.K. Shahid
Vol 22, No 6 (2015) Disparity in cancer prevention and screening in aboriginal populations: recommendations for action Abstract   PDF   HTML
S. Ahmed, R.K. Shahid, J.A. Episkenew
Vol 18, No 5 (2011) Distress—the 6th vital sign Details   PDF   HTML
D. Howell, K. Olsen
Vol 22, No 1 (2015) Distribution and clinical significance of TAMs in pancreatic ductal adenocarcinoma: A retrospective analysis in China Abstract   PDF   HTML
S.J. Chen, Q.B. Zhang, L.J. Zeng, G.D. Lian, J.J. Li, C.C. Qian, Y.Z. Chen, Y.T. Chen, K.H. Huang
Vol 15, No 5 (2008) Do Bone Metastases from Gastrointestinal Cancers Produce Similar Response Rates Following Radiotherapy When Compared to Bone Metastases from Other Primary Cancers? Abstract   PDF
Amanda Elizabeth Hird, Edward Chow, Darwin Yip, Michelle Ross, Stephanie Hadi, Candi Flynn, Emily Sinclair, Yoo-Joung Ko
Vol 20, No 1 (2013) Do current cancer follow-up care practices meet the needs of young adult cancer survivors in Canada? A qualitative inquiry Abstract   PDF   HTML
B. Miedema, J. Easley, L.M. Robinson
Vol 15, No 2 (2008) Do statins prevent or promote cancer? Abstract   PDF
Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
Vol 20, No 4 (2013) Do we need another selective estrogen receptor modulator for the adjuvant treatment of breast cancer? Abstract   PDF   HTML
T. Shenkier
Vol 22, No 3 (2015) Doctor, what are my options? A prospective cohort study of an individualized care plan for patients with gastrointestinal cancer Abstract   PDF   HTML
A.E. Hird, M. Lemke, M. Turovsky, V. Malecki, K. Kumar, C. DeAngelis, E. Chow, Y.J. Ko
301 - 400 of 1444 Items << < 1 2 3 4 5 6 7 8 9 10 > >>